CAREDX, INC. Deferred Tax Assets, Tax Deferred Expense
CAREDX, INC. (CDNA) had Deferred Tax Assets, Tax Deferred Expense of $8.32 million as of 2025-12-31, per its 10-K filed 2026-02-25.
Financial Statements › Notes › Income Taxes › Components of Deferred Tax Assets and Liabilities › Components of Deferred Tax Assets › Deferred Tax Assets, Net › Deferred Tax Assets, Net of Valuation Allowance › Deferred Tax Assets, Gross › Deferred Tax Assets, Tax Deferred Expense
us-gaap:DeferredTaxAssetsTaxDeferredExpense · last filed 2026-02-25
- 2025-12-31: Deferred Tax Assets, Tax Deferred Expense $8.32M.
- 2024-12-31: Deferred Tax Assets, Tax Deferred Expense $5.03M.
- 2023-12-31: Deferred Tax Assets, Tax Deferred Expense $26.26M.
- 2022-12-31: Deferred Tax Assets, Tax Deferred Expense $2.97M.
| Period end | Deferred Tax Assets, Tax Deferred Expense |
|---|---|
| 2025-12-31 | $8.32M 10-K · filed 2026-02-25 |
| 2024-12-31 | $5.03M 10-K · filed 2026-02-25 |
| 2023-12-31 | $26.26M 10-K · filed 2025-02-28 |
| 2022-12-31 | $2.97M 10-K · filed 2024-02-28 |
| 2021-12-31 | $6.05M 10-K · filed 2023-02-27 |
| 2020-12-31 | $4.60M 10-K · filed 2022-02-24 |
| 2019-12-31 | $2.65M 10-K · filed 2021-02-24 |
| 2018-12-31 | $3.07M 10-K · filed 2020-02-28 |
| 2017-12-31 | $583.00K 10-K · filed 2019-03-06 |
| 2016-12-31 | $1.27M 10-K · filed 2018-03-22 |
| 2015-12-31 | $1.13M 10-K · filed 2017-04-21 |
| 2014-12-31 | $942.00K 10-K · filed 2016-03-29 |
| 2013-12-31 | $1.10M 10-K · filed 2015-03-31 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Celcuity Inc. (CELC) | United States | $3.887B | -22.62 |
| VERACYTE, INC. (VCYT) | United States | $3.904B | 41.21 |
| Fortrea Holdings Inc. (FTRE) | United States | $1.903B | -19.43 |
| Personalis, Inc. (PSNL) | United States | $1.769B | -13.30 |
| CASTLE BIOSCIENCES INC (CSTL) | United States | $1.074B | -37.45 |
| Lumexa Imaging Holdings, Inc. (LMRI) | United States | $0.951B | |
| GRAIL, Inc. (GRAL) | United States | $5.591B | -7.78 |
| RadNet, Inc. (RDNT) | United States | $5.611B | -229.65 |
| Fulgent Genetics, Inc. (FLGT) | United States | $0.593B | -6.70 |
| BIODESIX INC (BDSX) | United States | $0.312B |